ReNerve Quarterly Investor Update
Development of Novel Nerve Repair & Regeneration Products ReNerve is focused on developing a portfolio of products for the nerve… Read more
ReNerve Limited – Quarterly Activities Report for the Period Ended 31 December 2024
Highlights: • ReNerve Limited (“ReNerve” or “the Company”) commenced trading on the ASX on 26 November 2024 following a heavily… Read more
ReNerve Signs Exclusive Partnership with Established Supplier in the Middle East to Further Accelerate International Expansion
Highlights: ● ReNerve Limited has partnered with Union MediScience B.S.C in an exclusive distribution agreement for the sales and marketing… Read more
ReNerve Signs Exclusive Partnership with Leading Distributor in Hong Kong to Accelerate International Expansion
Highlights: ● ReNerve Limited has partnered with Accession Medical Supplies Co in an exclusive distribution agreement for sales and marketing… Read more
ReNerve Presentation
ReNerve is pleased to provide its latest Investor Presentation.
ReNerve – Commencement of Trade as ReNerve Limited Looks to Progress Product Portfolio
Highlights: • ReNerve Limited to commence trading on the ASX at 12:00pm (AEDT) today (26 November 2024) under the ticker… Read more